Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials

CONCLUSIONS: Our current results suggested that when considering both safety and efficacy, denosumab or teriparatide might be a better choice for women with postmenopausal osteoporosis.PMID:37750653 | DOI:10.26355/eurrev_202309_33586

Source: European Review for Medical and Pharmacological Sciences - September 26, 2023 Category: Drugs & Pharmacology Authors: W-Y Wang L-H Chen W-J Ma R-X You Source Type: research